LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,903 | -17.8% | 716 | -1.1% | 0.00% | – |
| Q2 2023 | $52,200 | +106430.6% | 724 | +9.0% | 0.00% | – |
| Q1 2023 | $49 | +11.4% | 664 | 0.0% | 0.00% | – |
| Q4 2022 | $44 | -99.9% | 664 | 0.0% | 0.00% | – |
| Q3 2022 | $58,000 | 0.0% | 664 | +1.8% | 0.00% | -100.0% |
| Q2 2022 | $58,000 | -31.8% | 652 | -13.3% | 0.00% | 0.0% |
| Q1 2022 | $85,000 | -4.5% | 752 | +5.2% | 0.00% | 0.0% |
| Q4 2021 | $89,000 | -11.0% | 715 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $100,000 | +6.4% | 715 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $94,000 | -13.8% | 715 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $109,000 | +113.7% | 715 | +38.8% | 0.00% | – |
| Q4 2020 | $51,000 | -51.9% | 515 | -53.8% | 0.00% | -100.0% |
| Q3 2020 | $106,000 | +65.6% | 1,115 | +93.9% | 0.00% | 0.0% |
| Q2 2020 | $64,000 | -42.3% | 575 | -62.4% | 0.00% | 0.0% |
| Q1 2020 | $111,000 | -15.3% | 1,530 | +21.4% | 0.00% | 0.0% |
| Q4 2019 | $131,000 | +23.6% | 1,260 | +18.9% | 0.00% | 0.0% |
| Q3 2019 | $106,000 | +863.6% | 1,060 | +960.0% | 0.00% | – |
| Q2 2019 | $11,000 | -15.4% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $13,000 | -7.1% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $14,000 | -99.3% | 100 | -98.7% | 0.00% | -100.0% |
| Q3 2018 | $2,153,000 | +6845.2% | 7,843 | +5128.7% | 0.02% | – |
| Q2 2018 | $31,000 | +82.4% | 150 | +50.0% | 0.00% | – |
| Q1 2018 | $17,000 | -19.0% | 100 | -33.3% | 0.00% | – |
| Q4 2017 | $21,000 | +5.0% | 150 | 0.0% | 0.00% | – |
| Q3 2017 | $20,000 | +11.1% | 150 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | +12.5% | 150 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | +6.7% | 150 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -63.4% | 150 | -62.5% | 0.00% | -100.0% |
| Q3 2016 | $41,000 | -14.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $48,000 | +11.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $43,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |